Shukla Abhinav A.
Transaction: 07/06/2026
SELL
Change
-12,153
Price
$3.57
Filing
07/07/2026
Type
SELL
Shattuck Labs, Inc.
STTK • Biotechnology
$6.79
▼ -0.17 (-2.44%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$881.20M
Growth
-48.5%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.02Healthy liquidity · 11.7Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:53 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$6.79
Change-2.44%
Shares Out129.78M
Market Cap$881.20M
Enterprise Value$819.70M
52W Range0.79 - 8.33
Beta1.11
P/E-16.76
P/S881.20
P/B4.17
P/FCF-21.37
EV/Sales819.70
Price$6.79
Change-2.44%
Shares Out129.78M
Market Cap$881.20M
Enterprise Value$819.70M
52W Range0.79 - 8.33
Beta1.11
P/E-16.76
P/S881.20
P/B4.17
P/FCF-21.37
EV/Sales819.70
EV/EBITDA-15.64
EV/FCF-19.88
Earnings Yield-5.97%
FCF Yield-4.68%
Dividend Yield0.00%
Gross Margin100.00%
Oper. Margin-51.51%
Profit Margin-48.81%
Debt/Eq0.02
Current Ratio11.70
Quick Ratio11.70
Revenue 5Y-48.48%
Target$13.20
Target Upside94.40%
Target Median$14.00
Target Range7.00 - 18.00
Volume677.81K
Avg Volume1.04M
EPS Surprise0.01
Investment DNA
How strong this company looks for long-term investors
34
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
49/100
Why this score▼
Manageable debt level · 0.02Healthy liquidity · 11.7Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 9 analyst votes · 2026-09-05
100/100
Bullish
Bullish
9
Hold
0
Bearish
0
Price Target
2026-08-14
Low
$7.00
Mean
$12.00
Median
$12.50
High
$16.00
Insider Transactions
Recent executive and insider activity
⚠ 2 high-volume insider sells detected
Shukla Abhinav A.
Transaction: 07/06/2026
BUY
Change
+12,153
Price
$3.57
Filing
07/07/2026
Type
BUY
Shukla Abhinav A.
Transaction: 07/02/2026
SELL
Change
-410
Price
$3.57
Filing
07/07/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Shukla Abhinav A. | SELL | -12,153 | $3.57 | 07/06/2026 | 07/07/2026 |
| Shukla Abhinav A. | BUY | +12,153 | $3.57 | 07/06/2026 | 07/07/2026 |
| Shukla Abhinav A. | SELL | -410 | $3.57 | 07/02/2026 | 07/07/2026 |
| Shukla Abhinav A. | SELL | -410 | $7.01 | 07/02/2026 | 07/07/2026 |
| Shukla Abhinav A. | SELL | -100 | $3.57 | 07/01/2026 | 07/02/2026 |
| Shukla Abhinav A. | SELL | -100 | $7.07 | 07/01/2026 | 07/02/2026 |
| Pandite Arundathy N. | SELL | -30,000 | $7.01 | 06/30/2026 | 07/02/2026 |
| Shukla Abhinav A. | SELL | -23,365 | $3.57 | 06/30/2026 | 07/02/2026 |
| Shukla Abhinav A. | SELL | -23,365 | $7.08 | 06/30/2026 | 07/02/2026 |
| ORBIMED ADVISORS LLC | BUY | +208,333 | $0.00 | 06/11/2026 | 06/15/2026 |
| Ashiya Mona | BUY | +208,333 | $0.00 | 06/11/2026 | 06/15/2026 |
| SIEGALL CLAY B | BUY | +62,500 | $4.00 | 06/09/2026 | 06/11/2026 |
| Ashiya Mona | SELL | -3,073,298 | $1.08 | 06/08/2026 | 06/09/2026 |
| Ashiya Mona | BUY | +3,073,298 | $0.00 | 06/08/2026 | 06/09/2026 |
| ORBIMED ADVISORS LLC | SELL | -3,073,298 | $1.08 | 06/08/2026 | 06/09/2026 |
| ORBIMED ADVISORS LLC | BUY | +3,073,298 | $0.00 | 06/08/2026 | 06/09/2026 |
| Boudreau Helen M | BUY | +81,000 | $5.95 | 05/29/2026 | 06/02/2026 |
| SIEGALL CLAY B | BUY | +81,000 | $5.95 | 05/29/2026 | 06/02/2026 |
| Ashiya Mona | BUY | +81,000 | $5.95 | 05/29/2026 | 06/02/2026 |
| Gibson Neil W | BUY | +81,000 | $5.95 | 05/29/2026 | 06/02/2026 |